Grab 20% Off With Code ONLINE20 On Global market Reports – Evaluate Global Trends, Market Risks, and Competitive Intelligence
What Is the Forecasted Market Size of the Lyme Disease Testing Market by 2029?
The lyme disease testing market size has grown strongly in recent years. It will grow from $9.77 billion in 2024 to $10.68 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increasing demand for early disease detection, growing availability of advanced diagnostic tools, rising incidence of tick populations due to climate change, increasing government funding for vector-borne disease control, and growing healthcare infrastructure in rural and endemic areas.
The lyme disease testing market size is expected to see strong growth in the next few years. It will grow to $15.11 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing travel to endemic regions, increasing use of multiplex diagnostic technologies, a rising number of outdoor recreational activities, growing demand for home-based testing kits, and rising concerns over co-infections with other tick-borne diseases. Major trends in the forecast period include advancements in molecular diagnostic techniques, advancements in biomarker research, technology innovation in point-of-care testing devices, developments in lab-on-a-chip (microfluidic) technology, and advancements in immunoassay technologies.
Get your free report sample today:
What Are the Major Drivers Propelling the Growth of the Lyme Disease Testing Market?
The rising prevalence of tick-borne illnesses is expected to propel the growth of the lyme disease testing market going forward. Tick-borne illnesses refer to a group of diseases that are transmitted to humans through the bite of infected ticks, which are small, blood-feeding parasites found in grassy, wooded, or rural areas. The rising demand for tick-borne illness treatments is fueled by the expanding geographic range of ticks caused by climate change, leading to higher exposure and infection rates. Tick-borne illnesses contribute to the demand for Lyme disease testing by serving as the primary mode of transmission for Lyme disease, necessitating early detection and diagnosis to manage rising infection cases effectively. For instance, in July 2024, according to the Centers for Disease Control and Prevention, a US-based federal public health agency, 71,346 cases of tick-borne disease were reported in 2022, an increase from 36,177 cases in 2021. Therefore, the rising prevalence of tick-borne illnesses is driving the growth of the lyme disease testing market.
How Is the Lyme Disease Testing Market Structured Across Its Key Segment Categories?
The lyme disease testing market covered in this report is segmented –
1) By Test Type: Serological Tests, Nucleic Acid Tests, Urine Antigen Tests, Other Test Types
2) By Testing Methodology: Enzyme-Linked Immunosorbent Assay (ELISA), Weste Blot, Polymerase Chain Reaction (PCR), Immunofluorescence Assay (IFA), Other Emerging Technologies
3) By Disease Stage: Early Lyme Disease, Disseminated Lyme Disease, Chronic Lyme Disease, Asymptomatic Lyme Disease Detection
4) By Sample Type: Blood, Urine, Cerebrospinal Fluid(CSF), Other Blood Samples
5) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Research Institutions, Public Health Organizations
Subsegments:
1) By Serological Tests: Enzyme-Linked Immunosorbent Assay, Western Blot, Immunofluorescence Assay (IFA), Line Immunoassay (LIA)
2) By Nucleic Acid Tests: Polymerase Chain Reaction (PCR), Loop-Mediated Isothermal Amplification (LAMP), Next-Generation Sequencing (NGS)
3) By Urine Antigen Tests: Lateral Flow Assay, Enzyme Immunoassay (EIA), Immunoblot Urine Tests
4) By Other Test Types: Culture-Based Tests, Tick-Borne Co-Infection Panels, Artificial Intelligence-Assisted Diagnostic Tools
What Are the Current Trends Influencing the Lyme Disease Testing Market?
Major companies operating in the Lyme disease testing market are focusing on technological advancements in diagnostic tools to enhance test accuracy, reduce turnaround times, and enable early-stage detection of the disease. Diagnostic tools refer to medical devices, kits, or technologies used to detect the presence of Lyme disease by identifying specific antibodies, antigens, or genetic material associated with the Borrelia burgdorferi bacteria. For instance, in August 2024, EpitogenX Ltd., a UK-based biotechnology company, announced the launch of a cutting-edge Lyme Disease Diagnostic Kit. It is an ELISA-based assay crafted using their proprietary EpitoGen platform. It features ~120 distinct Borrelia epitopes, offering high specificity and sensitivity, and is tailored for research use (RUO). It supports early, strain-specific detection and can be customized for different laboratory applications. Designed for research and diagnostic labs, it's ideal for improving detection accuracy and enabling deeper insights into Lyme disease.
Which Companies Are Recognized as Major Innovators in the Lyme Disease Testing Market?
Major companies operating in the lyme disease testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific, BIOMÉRIEUX, Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A, Meridian Bioscience, Everlywell, Trinity Biotech, T2 Biosystems, IGeneX, Viramed Biotech AG, Ceres Nanosciences, Galaxy Diagnostics, Novatein Biosciences, Lyme Diagnostics Ltd
Get the detailed lyme disease testing market report today
Which Regional Markets Are Likely to See the Most Significant Expansion in the Coming Years?
North America was the largest region in the lyme disease testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lyme disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment